The NCD Alliance has strongly criticised what it describes as ‘pitiful’ investments in non-communicable diseases (NCD), and has urged immediate action to address financing in this area.
Speaking during a panel on NCD financing at the Interactive Hearing in Preparation for the 2018 High-Level Meeting (HLM) on NCDs last week, Katie Dain, CEO of NCD Alliance described how the amount of finance spent on NCDs was nine times less than that spent on HIV/AIDs. Dain said economies are being depleted by the direct and indirect costs of NCDs and highlighted the fact that the return on investment in NCDs significantly outweighs the costs.
The NCD Alliance chief presented a five-point plan on financing for NCDs which calls for political leadership on the issue, improved data on resource flows; and the implementation of fiscal policies for health, as well as providing catalytic development assistance for NCDs and leveraging both existing and new financing mechanisms for NCDs.
Dain said governments need to be “on the money to bend the curve on NCDs” which she said means “grasping the opportunity of the HLM, and going beyond the generic language previously agreed on financing to make concrete, tangible commitments”.